Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inspire Pharmaceuticals Inc (ISPH) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inspire Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1040416.
Total stock buying since 2010: $48,895.
Total stock sales since 2010: $57,886.
Total stock option exercises since 2010: $21,897.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 7,000 | $48,895 | 7,934 | $57,886 | 259,526 | $21,897 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-11 | 7,000 | $48,895 | 7,934 | $57,886 | 7,934 | $21,897 |
| 2010-06 | 0 | $0 | 0 | $0 | 1,592 | $0 |
| 2010-05 | 0 | $0 | 0 | $0 | 250,000 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-11-15 | Frey Kip (Director) | Sale | 7,934 | 7.30 | 57,886 |
| 2010-11-15 | Frey Kip (Director) | Option Ex | 7,934 | 2.76 | 21,897 |
| 2010-11-09 | Hutson Nancy J (Director) | Buy | 7,000 | 6.99 | 48,895 |
| 2010-06-03 | Abercrombie George B (Director) | Option Ex | 1,592 | .00 | 0 |
| 2010-05-19 | Koven Andrew I (EVP & Chief Admin & Legal Ofc) | Option Ex | 250,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ISPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inspire Pharmaceuticals Inc (symbol ISPH, CIK number 1040416) see the Securities and Exchange Commission (SEC) website.